You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ):擬變更審計機構
格隆匯 10-20 20:58

格隆匯 10 月 20日丨未名醫藥(002581.SZ)公佈,公司審計委員會提議司擬變更、聘任中興財光華會計師事務所(特殊普通合夥)為2020年度財務審計機構,聘期一年,並提請股東大會授權公司經營管理層根據市場慣例與會計師事務所協商確定其酬金。本議案尚需提交公司股東大會審議,自公司股東大會審議通過之日起生效。

公司原審計機構中喜會計師事務所(特殊普通合夥)(“中喜會計師事務所”)自擔任公司審計機構以來,嚴格遵守國家相關的法律、法規,獨立、客觀、公正地為公司提供了優質的審計服務,較好地完成了公司的各項審計相關工作,切實履行了審計機構職責。

鑑於公司業務發展需要中喜會計師事務所不再擔任公司審計機構。公司已就更換審計機構事項與中喜會計師事務所進行了事先溝通,中喜會計師事務所悉本事項並確認無異議。公司對中喜會計師事務所的辛勤工作表示由衷的感謝!

經公司董事會審計委員會提議,公司擬聘請中興財光華會計師事務所(特殊普通合夥)為公司2020年度審計機構,負責公司2020年度財務報告審計工作,聘任期限為一年,自股東大會審議通過之日起生效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account